These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 89849)

  • 21. [Computing pharmacokinetic parameters from blood level--time data of equi-interval samplings (author's transl)].
    Zhou HW
    Zhongguo Yao Li Xue Bao; 1980 Dec; 1(2):65-70. PubMed ID: 6461186
    [No Abstract]   [Full Text] [Related]  

  • 22. What happens in the skin? Integrating skin permeation kinetics into studies of developmental and reproductive toxicity following topical exposure.
    Dancik Y; Bigliardi PL; Bigliardi-Qi M
    Reprod Toxicol; 2015 Dec; 58():252-81. PubMed ID: 26475253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics in multiple dosage--2 examples].
    Biebler KE
    Z Arztl Fortbild (Jena); 1981 May; 75(10):470-2. PubMed ID: 7314661
    [No Abstract]   [Full Text] [Related]  

  • 24. [Model building in pharmacokinetics/Part I: General strategy (author's transl)].
    Bozler G; Heinzel G; Koss FW; Wolf M
    Arzneimittelforschung; 1977; 27(4a):897-900. PubMed ID: 577856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Model building in pharmacokinetics/Part II: Generalized theoretical presentation of complete integration of linear compartment models of optional structure (author's transl)].
    Wolf M; Heinzel G; Koss FW; Bozler G
    Arzneimittelforschung; 1977; 27(4a):900-4. PubMed ID: 577857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reasons for monitoring kinetics in safety evaluation studies.
    Hawkins DR; Chasseaud LF
    Arch Toxicol Suppl; 1985; 8():165-72. PubMed ID: 3868346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive approach for drug safety assessment.
    Li AP
    Chem Biol Interact; 2004 Nov; 150(1):27-33. PubMed ID: 15522259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics in chronic animal toxicity studies.
    Yacobi A; Kamath BL; Lai CM
    Drug Metab Rev; 1982; 13(6):1021-51. PubMed ID: 6754316
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectivity of drugs in the elderly with regard to their pharmacokinetics and pharmacodynamics (author's transl)].
    Coper H
    Arzneimittelforschung; 1980; 30(8):1183-5. PubMed ID: 7192132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Two aspects about curve fitting in pharmacokinetics; weighting of experimental data and discrimination between linear compartmental models (author's transl)].
    Zeng YL
    Yao Xue Xue Bao; 1980 Sep; 15(9):571-6. PubMed ID: 7234430
    [No Abstract]   [Full Text] [Related]  

  • 31. [Model building in pharmacokinetics/Part IV: Derivation of microconstants in linear compartment models (author's transl)].
    Heinzel G; WOLF M; Hammer R; Koss FW; Bozler G
    Arzneimittelforschung; 1977; 27(4a):912-28. PubMed ID: 577859
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds.
    Gillette JR
    Drug Metab Rev; 1979; 10(1):59-87. PubMed ID: 118860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Editorial: A second life for medicine (author's transl)].
    Glasson B
    Schweiz Rundsch Med Prax; 1974 May; 63(18):543-4. PubMed ID: 4831242
    [No Abstract]   [Full Text] [Related]  

  • 34. [The importance of age dependent changes of the organism for therapy (author's transl)].
    Platt D
    Aktuelle Gerontol; 1978 Jun; 8(6):297-301. PubMed ID: 27107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics parameters of the gastrointestinal absorption of drugs (author's transl)].
    Lesne M
    J Pharm Belg; 1975; 30(3):239-72. PubMed ID: 1485
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical pharmacokinetics in the causal treatment of acute intoxications (author's transl)].
    Lesne M; Jacqmin P; Bouchat JM; Mahieu P
    Therapie; 1981; 36(5):511-23. PubMed ID: 7034287
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biopharmaceutic and pharmacokinetic parameters in assessing pharmacopoeial drug quality standards (author's transl)].
    Zathurecký L
    Cas Lek Cesk; 1977 Apr; 116(16):481-5. PubMed ID: 872171
    [No Abstract]   [Full Text] [Related]  

  • 38. Primer on clinical pharmacokinetics.
    Bauer LA
    Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic considerations in toxicity testing.
    Jollow DJ; Roberts S; Price V; Longacre S; Smith C
    Drug Metab Rev; 1982; 13(6):983-1007. PubMed ID: 6754320
    [No Abstract]   [Full Text] [Related]  

  • 40. [P-450 cytochromes and mono-oxygenases. Mechanism of action. Consequences in pharmacology and toxicology (author's transl)].
    Mansuy D
    Ann Biol Clin (Paris); 1980; 38(1):19-23. PubMed ID: 7377646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.